PCLAF and breast carcinoma: These results are in accordance with the work of Bussolati et al.14 showing that endogenous or exogenous administration of PAF induces an increase in cell proliferation in breast cancer cells that express the PAF receptor without affecting proliferation in PAF receptor-negative breast cancer.